Drug Profile
APG 8361
Alternative Names: APG-8361Latest Information Update: 30 Aug 2016
Price :
$50
*
At a glance
- Originator Ascentage Pharma
- Class Antineoplastics; Small molecules
- Mechanism of Action Proto-oncogene protein c-met inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cancer
Most Recent Events
- 30 Aug 2016 Phase-II clinical trials in Cancer in China (unspecified route) before August 2016